Pathogenesis of immune-mediated neuropathies

Pediatric Research

Volumn 33, Issue 1, 1993, Pages S90-S94

  Rostami, A M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTONOMIC DYSFUNCTION; COLLAGEN DISEASE; CONFERENCE PAPER; DISEASE ASSOCIATION; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE MEDIATED INJURY; LYME DISEASE; NEUROPATHY; PARAPROTEINEMIA; PATHOGENESIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RESPIRATORY FAILURE;

ADULT; ANIMAL; CHILD; DEMYELINATING DISEASES; FEMALE; HIV INFECTIONS; HUMAN; LYME DISEASE; MALE; PARAPROTEINEMIAS; PERIPHERAL NERVOUS SYSTEM DISEASES; POLYRADICULONEUROPATHY; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027538107     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/00006450-199304001-00016     Document Type: Article

References (70)

1. Asbury AK 1981 Diagnostic considerations in Guillain-Barre syndrome. Ann Neurol 9(suppl): 1-5
2. McKhann GM 1990 Guillain-Barre syndrome: clinical and therapeutic observations. Ann Neurol 27(suppl):S13-S16
3. Schoenberger LD, Hurwitz ES, Katona P, Holman RC, Bregman DJ 1981 Guillain-Barre syndrome: its epidemiology and association with influenza vaccination. Ann Neurol 9(suppl):31-38
4. Hurwitz ES, Holman RC, Nelson DB, Schoenberger LB 1983 National surveillance for Guillain-Barre syndrome January 1978-March 1979. Neurology 33:156-157
5. Sladky JT 1987 Neuropathy in childhood. Semin Neurol 7:65-75
6. Cook SD, Dowling PC, Blumberg BM 1987 Infection and autoimmunity in Guillain-Barre syndrome. Clin Neuroimmunol 17:225-240
7. Kaldor J, Speed RB 1984 Guillain-Barre syndrome and Campylobacter jejuni: A serological study. Br Med J 228:1867-1870
8. Gruenewald R, Ropper AH, Lior H, Chan J, Lee R, Molinaro VS 1991 Serologic evidence of Campylobacter jejuni/co\i enteritis in patients with Guillain-Barre syndrome. Arch Neurol 48:1080-1082
9. Parry GJ 1988 Peripheral neuropathies associated with human immunodefi ciency virus infection. Ann Neurol 23(suppl):S46-S53
10. Pachner AR, Steere RA 1985 The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology 35:4753
11. Waksman BH, Adams RD 1985 Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants. J Exp Med 102:213-236
12. Smith ME, Hofmann WW 1979 Experimental allergic neuritis in the Lewis rat. J Neuropathol Exp Neurol 38:377-391
13. Brostoff SW, Burnett P, Lampert P 1972 Isolation and characterization of a protein from sciatic nerve myelin responsible for experimental allergic neuritis. Nature 235:210-212
14. Rostami A, Brown MJ, Lisak RP, Sumner AJ, Zweiman B, Pleasure DE 1984 The role of myelin P2 protein in the production of experimental allergic neuritis. Ann Neurol 16:680-685
15. Saida T, Saida K, Silberberg DH, Brown MJ 1981 Experimental allergic neuritis induced by galactocerebroside. Ann Neurol 9(suppl):S87-S101
16. Rostami AM, Gregorian SK, Brown MJ, Pleasure DE 1990 Induction of severe experimental autoimmune neuritis with a synthetic peptide corresponding to the 53-78 amino acid sequence of the myelin P2 protein. J Neuroimmunol 30:145-151
17. Rosen JL, Brown MJ, Hickey WF, Rostami AM 1990 Early myelin lesions in experimental allergic neuritis. Muscle Nerve 13:629-636
18. Rostami A, Burns JB, Brown MJ, Lisak RP, Pleasure DE 1983 Transfer of experimental allergic neuritis (EAN) with P2-reactive T cells. Ann Neurol 14:108 (abstr)
19. Rostami A, Burns JB, Brown MJ, Rosen J, Zweiman B, Lisak RP, Pleasure DE 1985 Transfer of experimental allergic neuritis with P2-reactive T cell lines. Cell Immunol 91:354-361
20. Linington C, Izumo S, Suzuki M, Uyemura K, Meyermann R, Wekerle H 1984 A permanent rat T-cell line that mediates experimental allergic neuritis in the Lewis rat in vivo. J Immunol 133:1946-1950
21. Rostami AM, Gregorian SK 1991 Peptide 53-78 of myelin P2 protein is a T-cell epitope for the induction of experimental autoimmune neuritis. Cell Immunol 132:1-8
22. Wekerle H, Schwab M, Linington C, Meyermann R 1986 Antigen presentation in the peripheral nervous system: Schwann cells present endogenous myelin autoantigens to lymphocytes. Eur J Immunol 16:1551-1557
23. Kimura H, Silvers WK, Ventura E, Honda H, Rostami AM 1989 Perivascular macrophages as the antigen-presenting cells in the peripheral nervous system. Neurology 39(suppl l):174(abstr)
24. Rostami AM, Honda H 1991 Expression of major histocompatibility complex class II antigen in experimental allergic neuritis. Neurology 41:188(abstr)
25. Schmidt B, Stoli G, Hartung HP, Heininger K, Schafer B, Toyka KV 1990 Macrophages but not Schwann cells express la antigen in experimental autoimmune neuritis. Ann Neurol 28:70-77
26. Hart NH, Hanks DT, Mackay A 1972 Ultrastructural observations in Guillain-Barre syndrome. Arch Pathol 93:552-555
27. Saida K, Sumner AJ, Saida T 1980 Antiserum-mediated demyelination: Relationship between remyelination and functional recovery. Ann Neurol 8:1224
28. Stoli G, Schwendemann G, Heininger K, Kohne W, Hartung H-P, Seitz RJ, Toyka KV 1986 Relation of clinical, serological, morphological and electrophysiological findings in galactocerebroside-induced experimental allergic neuritis. J Neurol Neurosurg Psychiatry 49:258-264
29. Bradford JR, Bashford EF, Wilson JA 1919 Acute infective polyneuritis. Quart J Med 12:88-103
30. Marek J 1907 Multiple nerventzundung (polyneuritis) bei Huhnern. Dtsch Tierarztl Wochenschr 15:417
31. Asbury AK, Arnason BG, Adams RD 1969 The inflammatory lesion in idiopathic polyneuritis: its role in pathogenesis. Medicine 48:173-215
32. Abramsky O, Webb C, Teitelbaum D, Arnon R 1975 Cell-mediated immunity for neuronal antigens in idiopathic polyneuritis and myeloradiculitis. Neurology 25:1154-1159
33. Sheremata W, Colby S, Karkhansis Y, Eylar E 1975 Cellular hypersensitivity to basic myelin (P2) protein in Guillain-Barre syndrome. Can J Neurol Sci 2:87-90
34. Iqbal A, Oger J-F, Arnson BGW 1981 Cell-mediated immunity in idiopathic polyneuritis. Ann Neurol 9(suppl):65-69
35. Zweiman B, Rostami AM, Lisak RP 1983 Immune responses to P2 protein in the human inflammatory demyelinative neuropathies. Neurology 33:234-237
36. Arnason BGW, Winkler GJ, Hadler NM 1969 Cell-mediated demyelination of peripheral nerve in tissue culture. Lab Invest 1:1-10
37. Lisak RP, Zweiman B, Guerrero F, Moskovitz AR 1985 Circulating T cell subsets in Guillain-Barre syndrome. J Neuroimmunol 8:93-101
38. Hughes RA, Asia CS, Gray IA 1983 Lymphocyte subpopulations and sup pressor cell activity in acute polyradiculoneuritis (Guillain-Barre syndrome). Clin Exp Immunol 51:448-454
39. Hauser SL, Ropper AH, Perlo VP, Reinherz EL, Schlossmann SF, Weiner HL 1982 T-cell subsets in human autoimmune disease. Neurology 32:1321-1322
40. Hartung HP, Reiners K, Schmidt B, Stoli G, Toyka KV 1991 Serum interleu-kin-2 concentrations in Guillain-Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis. Ann Neurol 30:48-53
41. Hartung HP, Hughes RAC, Taylor WA, Heininger K, Reiners K, Toyka KV 1990 T cell activation in Guillain-Barre syndrome and in MS: elevated serum levels of soluble IL-2 receptors. Neurology 40:215-218
42. Pollard JD, Baverstock J, McLeod JG 1987 Class II antigen expression and inflammatory cells in Guillain-Barre syndrome. Ann Neurol 21:337-341
43. Rostami AM, Eccleston PA, Silberberg DH, Manning MC, Burns JB, Lisak RP 1987 Search for antibodies to galactocerebroside in the sera and cerebrospinal fluid in human demyelinating disorders. Ann Neurol 22:381-383
44. Saida T, Saida K, Lisak RP, Brown MJ, Silberberg DH, Asbury AK 1982 In vivo demyelinating activity of sera from patients with Guillain-Barre syndrome. Ann Neurol 11:69-75
45. Goust JM, Chenais F, Carnes J, Hames CG, Fudenberg HH, Hogan EL 1978 Abnormal T cell subpopulations and circulating immune complexes in Guillain-Barre syndrome and multiple sclerosis. Neurology 28:421-425
46. Koski CL, Gratz E, Sutherland J, Mayer RF 1986 Clinical correlation with antiperipheral myelin antibodies in Guillain-Barre syndrome. Ann Neurol 19:573-577
47. Koski CL 1990 Characterization of complement-fixing antibodies to peripheral nerve myelin in Guillain-Barre syndrome. Ann Neurol 27(suppl):S44-S47
48. Ilyas AA, Willison HJ, Quarles RH, Jungalwala FB, Cornblath DR, Trapp BD, Griffin DE, Griffin JW, McKhann GM 1988 Serum antibodies to ganglio-sides in Guillain-Barre syndrome. Ann Neurol 23:440-447
49. Yu R, Ariga T, Kohriyama T, Kusunoki S, Maeda Y, Miyatani N 1990 Autoimmune mechanisms in peripheral neuropathies. Ann Neurol 27(suppl):S30-S35
50. Ropper AH, Shahani BT 1984 Diagnosis and management of acute areflexic paralysis with emphasis on Guillain-Barre syndrome. In: Asbury K, Gilliatt R (eds) Peripheral Nerve Disorders, A Practical Approach, Vol 2. Butter-worths, Boston, pp 21-45
51. The Guillain-Barre Syndrome Study Group 1985 Plasmapheresis and acute Guillain-Barre syndrome. Neurology 35:1096-1104
52. Hughes RAC, Newson-Davis CJ, Perkins GD, Pierce JM 1978 Controlled trial of prednisone in acute polyneuropathy. Lancet 2:750-753
53. Surik HM, McQuillen MP 1976 The use of steroids in the treatment of idiopathic polyneuritis. Neurology 25:205-212
54. Pollard JD 1987 A critical review of therapies in acute and chronic inflam-matory demyelinating polyneuropathies. Muscle Nerve 10:214-221
55. van der Meche FGA, Schmitz PIM, the Dutch Guillain-Barre Study Group 1992 A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. N Engl J Med 326:1123-1129
56. Dyck PJ, Lais AC, Ohta M, Bastron JA, Okazaki H, Groover RL 1975 Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 50:621-627
57. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR 1989 Chronic inflammatory demyelinating polyradiculoneuropathy. Arch Neurol 46:878-884
58. Pollard JD, McCombe PA, Baverstock J, Gatenby PA, McLeod JG 1986 Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 13:123-134
59. Lisak RP, Brown MJ 1987 Acquired demyelinating polyneuropathies. Semin Neurol 7:40-48
60. Dyck PJ, Daube J, O'Brien P, Pineda A, Low PA, Windebank AJ, Swanson C 1986 Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 314:461-465
61. Vermeulen M, van Der Meche FGA, Speelman JD, Weber A, Busch HFM 1985 Plasma and gamma globulin infusion in chronic inflammatory polyneuropathy. J Neurol Sci 70:317-326
62. Latov N 1987 Peripheral neuropathy and IgM monoclonal gammopathy. In: Aarli JA, Behan WMH, Behan, PO (eds) Clinical Neuroimmunology. Black-well, Oxford, UK, pp 214-224
63. Steck AJ, Murray N, Dellagi K, Brouet JC, Seligmann M 1987 Peripheral neuropathy associated with monoclonal IgM autoantibody. Ann Neurol 22:764-767
64. Bardwick PA, Zvaifler WJ, Gill GN, Newman D, Greenway GD, Resnick DL 1980 Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrino-pathy, M-protein, and skin changes: the POEMS syndrome. Medicine 59:311-322
65. Latov N, Hays AP, Donofio PD, Liao J, Ito H, McGinnis S, Manoussos K, Freddo L, Shy ME, Sherman WH, Chang HW, Greenberg HS, Albers JW, Alessi AG, Keren D, Yu RK, Rowland LP, Kabat EA 1988 Monoclonal IgM with unique specificity to gangliosides GM1 and GDlb and to lacto-N-tetrose association with human motor neuron disease. Neurology 38:763-768
66. Shy ME, Heiman-Patterson T, Parry GJ, Tahmoush AJ, Evans VA, Schick PK 1988 Motor neuropathy in a patient with autoantibodies against ganglio-sides GM1 and GDlb: improvement following immunotherapy. Neurology 38(suppl l):252(abstr)
67. Cornblath DR, McArthur JC, Kennedy PGE, Witte AS, Griffin JW 1987 Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotrophic virus type III (HIV) infection. Ann Neurol 21:32-40
68. Vallat JM, Hugon J, Lubeau M, Leboutet MJ, Dumas M, Desprogres-Gotteron R 1987 Tick-bite meningoradiculoneuritis: clinical electrophysiologic and histologic findings in 10 cases. Neurology 37:749-753
69. Halperin JJ, Little BW, Coyle PK, Dattwyler RJ 1987 Lyme disease: cause of a treatable peripheral neuropathy. Neurology 37:1700-1706
70. Hartung HP, Heininger K, Schafer B, Fierz W, Toyka KV 1988 Immune mechanisms in inflammatory polyneuropathy. Ann NY Acad Sci 540:122-161